Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
- 31 December 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3), 417-418
- https://doi.org/10.1016/0959-8049(94)90276-3
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Side effects of 6‐azauridine triacetate in rheumatoid arthritisClinical Pharmacology & Therapeutics, 1970